You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?
Scanfil: Still cheap!
Analyst Antti Viljakainen gives his thoughts on Scanfil’s recent profit warning, forecasts and valuation.
Content:
00:00 Intro
00:09 Profit warning
01:13 Profit warning’s impact to estimates
01:54 Recommendation
Aktier i Vælten - Novo Nordisk: Vi må vente på re-eksamen efter skuffende data
Introduction to the Helsinki Stock Exchange | Company Night Dec. 16, 2024
Surgical Science Sweden, Audiocast with teleconference, Press Conference, 2024
GomSpace – Management Q&A
ExpreS2ion Biotech – A look back at 2024 with CEO
View all videos